Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mrishta Appayya, J. Adshead, H. Ahmed, C. Allen, A. Bainbridge, T. Barrett, F. Giganti, J. Graham, P. Haslam, E. Johnston, C. Kastner, A. Kirkham, Alexandra Lipton, A. McNeill, Larissa Moniz, C. Moore, G. Nabi, A. Padhani, C. Parker, Amit Patel, J. Pursey, J. Richenberg, J. Staffurth, J. Meulen, Darren Walls, S. Punwani (2018)
National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meetingBju International, 122
(2019)
Very important because it refers to the last recommendation of PI-RADS, very useful in the daily clinical practice and for standardized reports
B. Turkbey, Maria Merino, E. Gallardo, V. Shah, O. Aras, M. Bernardo, E. Mena, D. Daar, A. Rastinehad, W. Linehan, B. Wood, P. Pinto, P. Choyke (2014)
Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathologyJournal of Magnetic Resonance Imaging, 39
Frederick Albright, R. Stephenson, N. Agarwal, C. Teerlink, W. Lowrance, J. Farnham, L. Albright (2014)
Prostate cancer risk prediction based on complete prostate cancer family historyThe Prostate, 75
J. Epstein, M. Zelefsky, D. Sjoberg, J. Nelson, L. Egevad, C. Magi-Galluzzi, A. Vickers, A. Parwani, V. Reuter, S. Fine, J. Eastham, P. Wiklund, Misop Han, C. Reddy, J. Ciezki, T. Nyberg, E. Klein (2016)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.European urology, 69 3
H. Ahmed, A. Bosaily, L. Brown, R. Gabe, R. Kaplan, M. Parmar, Y. Collaco-Moraes, Katie Ward, R. Hindley, A. Freeman, A. Kirkham, R. Oldroyd, C. Parker, M. Emberton (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyThe Lancet, 389
N. Mottet, J. Bellmunt, M. Bolla, E. Briers, M. Cumberbatch, M. Santis, N. Fossati, T. Gross, A. Henry, S. Joniau, T. Lam, M. Mason, V. Matveev, P. Moldovan, R. Bergh, T. Broeck, H. Poel, T. Kwast, O. Rouvière, I. Schoots, T. Wiegel, P. Cornford (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.European urology, 71 4
UICC International Union Against Cancer
M. Sadinski, M. Medved, I. Karademir, Shiyang Wang, Yahui Peng, Yulei Jiang, Steffen Sammet, G. Karczmar, A. Oto (2015)
Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostateAbdominal Imaging, 40
M. Litwin, Hung-Jui Tan (2017)
The Diagnosis and Treatment of Prostate Cancer: A ReviewJAMA, 317
E. Castro, C. Goh, D. Olmos, E. Saunders, D. Leongamornlert, M. Tymrakiewicz, N. Mahmud, Tokhir Dadaev, K. Govindasami, M. Guy, E. Sawyer, R. Wilkinson, A. Ardern-jones, Steve Ellis, D. Frost, S. Peock, D. Evans, M. Tischkowitz, T. Cole, R. Davidson, D. Eccles, C. Brewer, F. Douglas, M. Porteous, A. Donaldson, H. Dorkins, L. Izatt, J. Cook, S. Hodgson, M. Kennedy, L. Side, J. Eason, A. Murray, A. Antoniou, D. Easton, Z. Kote-Jarai, R. Eeles (2013)
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 14
R. Engels, B. Israël, A. Padhani, J. Barentsz (2020)
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.European urology
N. Grivas, K. Hinnen, J. Jong, W. Heemsbergen, L. Moonen, T. Witteveen, H. Poel, S. Heijmink (2018)
Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.European journal of radiology, 98
K. Esposito, P. Chiodini, A. Capuano, G. Bellastella, M. Maiorino, Elisabetta Parretta, A. Lenzi, D. Giugliano (2013)
Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysisJournal of Endocrinological Investigation, 36
G. Godoy, Basir Tareen, H. Lepor (2009)
Site of positive surgical margins influences biochemical recurrence after radical prostatectomyBJU International, 104
T. Kwee, T. Takahara, P. Luijten, R. Nievelstein (2010)
ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature.European journal of radiology, 75 2
B. Turkbey, A. Rosenkrantz, M. Haider, A. Padhani, G. Villeirs, K. Macura, C. Tempany, P. Choyke, F. Cornud, D. Margolis, H. Thoeny, S. Verma, J. Barentsz, J. Weinreb (2019)
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.European urology
K. Hemminki (2012)
Familial risk and familial survival in prostate cancerWorld Journal of Urology, 30
J. Weinreb, J. Barentsz, P. Choyke, F. Cornud, M. Haider, K. Macura, D. Margolis, M. Schnall, F. Shtern, C. Tempany, H. Thoeny, S. Verma (2016)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.European urology, 69 1
M. Arnold, H. Karim-Kos, J. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, A. Renehan, D. Forman, I. Soerjomataram (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory.European journal of cancer, 51 9
A. Zlotta, Epstein Ji, A. Wc (2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Glea- son Grading of Prostatic Carcinoma
G. Shen, H. Deng, Shuang Hu, Z. Jia (2014)
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysisSkeletal Radiology, 43
F. Soylu, Yahui Peng, Yulei Jiang, Shiyang Wang, C. Schmid-Tannwald, I. Sethi, S. Eggener, T. Antic, A. Oto (2013)
Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging.Radiology, 267 3
Elena Ventrella, L. Eusebi, F. Carpagnano, F. Bartelli, L. Cormio, G. Guglielmi (2020)
Multiparametric MRI of Prostate Cancer: Recent AdvancesCurrent Radiology Reports, 8
(2018)
Edn. presented at the EAU Annual Congress Copenhagen
J. Epstein, L. Egevad, M. Amin, B. Delahunt, J. Srigley, P. Humphrey (2015)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading SystemThe American Journal of Surgical Pathology, 40
D. Carter (1998)
TNM Classification of Malignant TumorsThe American Journal of Surgical Pathology, 22
D. Boehmer, P. Maingon, P. Poortmans, M. Baron, R. Miralbell, V. Remouchamps, C. Scrase, A. Bossi, M. Bolla (2006)
Guidelines for primary radiotherapy of patients with prostate cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 79 3
C. Kim, S. Park, J. Park, B. Park (2014)
Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.AJR. American journal of roentgenology, 202 3
A. Padhani, F. Lecouvet, N. Tunariu, D. Koh, F. Keyzer, D. Collins, E. Sala, H. Schlemmer, G. Petralia, H. Vargas, S. Fanti, H. Tombal, J. Bono (2017)
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate CancerEuropean Urology, 71
M. Leitzmann, S. Rohrmann (2012)
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlatesClinical Epidemiology, 4
J. Epstein, W. Allsbrook, M. Amin, L. Egevad (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaThe American Journal of Surgical Pathology, 29
F. Giganti, Andrea Coppola, A. Ambrosi, S. Ravelli, A. Esposito, M. Freschi, A. Briganti, V. Scattoni, A. Salonia, A. Gallina, F. Dehò, G. Cardone, G. Balconi, F. Gaboardi, F. Montorsi, A. Maschio, F. Cobelli (2016)
Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use.Urologic oncology, 34 7
A. Rosenkrantz, A. Shanbhogue, Annie Wang, M. Kong, J. Babb, S. Taneja (2016)
Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal thresholdJournal of Magnetic Resonance Imaging, 43
(1801)
Collaborators MRI-targeted or standard biopsy for prostate-cancer diagnosis
A. Morlacco, Vidit Sharma, B. Viers, L. Rangel, R. Carlson, Adam Froemming, R. Karnes (2017)
The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy.European urology, 71 5
E. Castro, C. Goh, D. Leongamornlert, E. Saunders, M. Tymrakiewicz, Tokhir Dadaev, K. Govindasami, M. Guy, Steve Ellis, D. Frost, E. Bancroft, T. Cole, M. Tischkowitz, M. Kennedy, J. Eason, C. Brewer, D. Evans, R. Davidson, D. Eccles, M. Porteous, F. Douglas, J. Adlard, A. Donaldson, A. Antoniou, Z. Kote-Jarai, D. Easton, D. Olmos, R. Eeles (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.European urology, 68 2
A. Larbi, P. Omoumi, V. Pasoglou, N. Michoux, P. Triqueneaux, B. Tombal, C. Cyteval, F. Lecouvet (2018)
Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequencesEuropean Radiology, 29
T. Barrett, A. Priest, Edward Lawrence, D. Goldman, A. Warren, V. Gnanapragasam, E. Sala, F. Gallagher (2015)
Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate.AJR. American journal of roentgenology, 205 6
K. Rayn, Jonathan Bloom, Samuel Gold, Graham Hale, Joseph Baiocco, Sherif Mehralivand, M. Czarniecki, Vikram Sabarwal, Vladimir Valera, B. Wood, M. Merino, P. Choyke, B. Turkbey, P. Pinto (2018)
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate CancerThe Journal of Urology, 200
T. Barrett, B. Turkbey, P. Choyke (2015)
PI-RADS version 2: what you need to know.Clinical radiology, 70 11
I. Caglic, I. Caglic, T. Barrett (2019)
Optimising prostate mpMRI: prepare for success.Clinical radiology
I. Caglic, P. Bržan, A. Warren, O. Bratt, N. Shah, T. Barrett (2019)
Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extensionEuropean Radiology, 29
D. Jung, H. Lee, S. Kim, G. Choe, Sang Lee (2008)
Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: Pattern analysis of seminal vesicle lesionsJournal of Magnetic Resonance Imaging, 28
I. Cagiannos, P. Karakiewicz, J. Eastham, M. Ohori, F. Rabbani, C. Gerigk, V. Reuter, M. Graefen, P. Hammerer, A. Erbersdobler, H. Huland, P. Kupelian, E. Klein, D. Quinn, S. Henshall, J. Grygiel, R. Sutherland, P. Stricker, C. Morash, P. Scardino, M. Kattan (2003)
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.The Journal of urology, 170 5
Lawrence Gervasi, J. Mata, J. Easley, J. Wilbanks, C. Seale-Hawkins, C. Carlton, P. Scardino (1989)
Prognostic significance of lymph nodal metastases in prostate cancer.The Journal of urology, 142 2 Pt 1
(2013)
Effect of metabolic syndrome and its components on prostate cancer risk: metaanalysis
V. Kasivisvanathan, A. Rannikko, M. Borghi, V. Panebianco, L. Mynderse, M. Vaarala, A. Briganti, L. Budäus, G. Hellawell, R. Hindley, M. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G. Villeirs, J. Virdi, S. Boxler, G. Robert, Paras Singh, W. Venderink, B. Hadaschik, A. Ruffion, Jim Hu, D. Margolis, S. Crouzet, L. Klotz, S. Taneja, P. Pinto, I. Gill, C. Allen, F. Giganti, A. Freeman, S. Morris, S. Punwani, N. Williams, C. Brew-Graves, J. Deeks, Y. Takwoingi, M. Emberton, C. Moore (2018)
MRI‐Targeted or Standard Biopsy for Prostate‐Cancer DiagnosisThe New England Journal of Medicine, 378
F. Barchetti, V. Panebianco (2014)
Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation TherapyBioMed Research International, 2014
M. Rooij, Esther Hamoen, J. Witjes, J. Barentsz, M. Rovers (2016)
Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.European urology, 70 2
E. Bancroft, E. Page, E. Castro, H. Lilja, A. Vickers, D. Sjoberg, M. Assel, C. Foster, G. Mitchell, Kate Drew, L. Mæhle, K. Axcrona, D. Evans, B. Bulman, D. Eccles, D. McBride, C. Asperen, H. Vasen, L. Kiemeney, J. Ringelberg, C. Cybulski, D. Wokołorczyk, C. Selkirk, P. Hulick, A. Bojesen, A. Skytte, Jimmy Lam, Louise Taylor, R. Oldenburg, R. Cremers, G. Verhaegh, W. Zelst-Stams, J. Oosterwijk, I. Blanco, Mónica Salinas, J. Cook, D. Rosario, S. Buys, T. Conner, M. Ausems, K. Ong, Jonathan Hoffman, S. Domchek, J. Powers, M. Teixeira, S. Maia, W. Foulkes, Nassim Taherian, M. Ruijs, Apollonia Enden, L. Izatt, R. Davidson, M. Adank, L. Walker, R. Schmutzler, K. Tucker, J. Kirk, S. Hodgson, M. Harris, F. Douglas, G. Lindeman, J. Zgajnar, M. Tischkowitz, V. Clowes, R. Susman, T. Cajal, Nicholas Patcher, N. Gadea, A. Spigelman, T. Os, A. Liljegren, L. Side, C. Brewer, A. Brady, A. Donaldson, V. Stefansdottir, E. Friedman, R. Chen-Shtoyerman, D. Amor, L. Copáková, J. Barwell, V. Giri, V. Murthy, N. Nicolai, S. Teo, L. Greenhalgh, S. Strom, A. Henderson, J. McGrath, D. Gallagher, N. Aaronson, A. Ardern-jones, C. Bangma, D. Dearnaley, P. Costello, J. Eyfjord, J. Rothwell, A. Falconer, H. Gronberg, F. Hamdy, O. Johannsson, V. Khoo, Z. Kote-Jarai, J. Lubiński, U. Axcrona, J. Melia, J. McKinley, A. Mitra, C. Moynihan, G. Rennert, M. Suri, Penny Wilson, E. Killick, S. Moss, R. Eeles (2014)
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyEuropean Urology, 66
J. Epstein, A. Partin, S. Potter, Patrick Walsh (2000)
Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.Urology, 56 2
P. Moldovan, T. Broeck, R. Sylvester, L. Marconi, J. Bellmunt, R. Bergh, M. Bolla, E. Briers, M. Cumberbatch, N. Fossati, T. Gross, A. Henry, S. Joniau, T. Kwast, V. Matveev, H. Poel, M. Santis, I. Schoots, T. Wiegel, C. Yuan, P. Cornford, N. Mottet, T. Lam, O. Rouvière (2017)
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.European urology, 72 2
I. Caglic, V. Kovač, T. Barrett (2019)
Multiparametric MRI - Local Staging of Prostate Cancer and BeyondRadiology and Oncology, 53
B. Park (2019)
Re: Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.033.European urology
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Purpose of ReviewTo highlight the recent evidence about the use of mp-MRI in the local staging of prostate cancer, enhancing the potential benefits compared to the known and more invasive canonical staging methods.Recent FindingsMultiparametric magnetic resonance (mp-MRI) plays a key role not only in diagnosis, but also in local staging of prostate cancer, as it can assess with high accuracy the extracapsular extension of the tumor, invasion of seminal vesicles, the involvement of lymph nodes and the presence of possible bone metastases.SummaryProstate cancer is currently the most common male cancer in Europe and it is associated with a high mortality rate, which is why it is necessary to make an early and accurate diagnosis. Firstly, it is important to distinguish between a disease confined to the gland and a disease with a loco regional or remote extension, since neoplastic staging is the starting point for risk stratification, prognosis and therapeutic planning. According to the PI-RADS guidelines v 2.1 the main mp-MRI sequences necessary to obtain a complete and accurate resonance imaging are the T2-weighted sequences (T2WI), which represent the pivotal morphological sequences for local staging, together with the diffusion-weighted imaging (DWI) and dynamic sequences acquired after intravenous contrast medium administration (DCE). However, due to some limitations, mp-MRI does not have the same diagnostic power in the evaluation of lymph nodes, for which the gold standard remains the extended pelvic nodal dissection (ePLND), nor in the detection of distant metastases. For this last aspect, the next generation imaging foresees the use of whole-body MRI (WB-MRI), especially for the high accuracy in the early detection of local and remote bone metastases.
Current Radiology Reports – Springer Journals
Published: Nov 4, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.